The Wall Street Journal
@wsj·6.6M subscribers·28.9K videos
Samsung Bioepis Seeks New Drug Approval
Posted
October 4, 2016
Views
1,490
Likes
19
Engagement
1.28%
October 4, 2016
1,490
19
1.28%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
1:04Now PlayingThe subsidiary of Samsung BioLogics, part of the Samsung Group conglomerate, has applied for European regulatory approval of its near-replica of a blockbuster breast-cancer drug. Photo: Samsung
Subscribe to the WSJ channel here:
More from the Wall Street Journal:
Visit WSJ.com
Follow WSJ on Facebook
Follow WSJ on Google+
Follow WSJ on Twitter
Follow WSJ on Instagram
Follow WSJ on Pinterest
Don’t miss a WSJ video, subscribe here
More from the Wall Street Journal:
Visit WSJ.com
Visit the WSJ Video Center
On Facebook
On Snapchat
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
